Use of oral VP16-213 as primary chemotherapeutic agent in treatment of gestational trophoblastic disease.
Am J Obstet Gynecol
; 150(8): 924-7, 1984 Dec 15.
Article
em En
| MEDLINE
| ID: mdl-6095666
ABSTRACT
Thirty-seven patients with persistent or metastatic gestational trophoblastic disease were treated with oral etoposide (VP16-213). All responded well and achieved permanent remission. The hematologic toxicity was mild. Alopecia was present in all patients. Etoposide is an effective drug against trophoblastic disease. In patients who have received chemotherapy for long periods oral etoposide would eliminate the problem of venous access.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Podofilotoxina
/
Neoplasias Uterinas
/
Neoplasias Trofoblásticas
/
Etoposídeo
Limite:
Female
/
Humans
/
Pregnancy
Idioma:
En
Revista:
Am J Obstet Gynecol
Ano de publicação:
1984
Tipo de documento:
Article